Matrix Capital Management Company, LP - 30 Dec 2025 SCHEDULE 13D/A Report for Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (ZNTL)

Filing Manager: Matrix Capital Management Company, LP
Reporting Manager: Matrix Capital Management Company, LP
Security: Zentalis Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: ZNTL
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Filing time: 02 Jan 2026, 16:10:52 UTC
Date of event: 30 Dec 2025
Previous filing: 15 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Matrix Capital Management Company, LP	0%	0	0	0	/s/ Gregory A. Brown	Gregory A. Brown, General Counsel, Chief Compliance Officer	0001410830
David E. Goel	0%	0	0	0	/s/ David E. Goel	David E. Goel, Individually	0001548144